Back to results
WithdrawnPhase 2Phase 3

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

NCT01211782

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Meridien Research

St. Petersburg, Florida, United States

View on ClinicalTrials.gov
AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) — TrialFind